Literature DB >> 20569002

Rat monoclonal antibody specific for MyoD.

Akihito Harada1, Yasuyuki Ohkawa, Shinpei Ao, Jun Odawara, Seiji Okada, Masayuki Azuma, Yuko Nishiyama, Mako Nakamura, Taro Tachibana.   

Abstract

Myogenic determination 1 (MyoD) is a myogenic regulatory factor (MRF) possessing a basic domain and a helix-loop-helix domain. MRFs play a critical role in myoblast fate and terminal differentiation. MyoD is a transcriptional factor that induces transcription by binding with gene regulatory factors expressed in skeletal muscle. As a master gene, MyoD also determines skeletal muscle differentiation. In this study, we established a monoclonal antibody specific for MyoD using the rat medial iliac lymph node method. Immunoblot analysis revealed that our monoclonal antibody against MyoD could identify full-length MyoD. Moreover, immunocytochemical staining revealed a change in the expression of MyoD at the skeletal muscle differentiation stage. This monoclonal antibody against MyoD allows for further studies to elucidate the mechanism by which MyoD influences skeletal muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569002     DOI: 10.1089/hyb.2009.0117

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  4 in total

1.  Production of a monoclonal antibody for C/EBPβ: the subnuclear localization of C/EBPβ in mouse L929 cells.

Authors:  Akihito Harada; Etsuko Okazaki; Seiji Okada; Taro Tachibana; Yasuyuki Ohkawa
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-02

2.  Chd2 interacts with H3.3 to determine myogenic cell fate.

Authors:  Akihito Harada; Seiji Okada; Daijiro Konno; Jun Odawara; Tomohiko Yoshimi; Saori Yoshimura; Hiromi Kumamaru; Hirokazu Saiwai; Toshiaki Tsubota; Hitoshi Kurumizaka; Koichi Akashi; Taro Tachibana; Anthony N Imbalzano; Yasuyuki Ohkawa
Journal:  EMBO J       Date:  2012-05-08       Impact factor: 11.598

3.  Identification of Immunoglobulin Gene Sequences from a Small Read Number of mRNA-Seq Using Hybridomas.

Authors:  Yuki Kuniyoshi; Kazumitsu Maehara; Takeshi Iwasaki; Masayasu Hayashi; Yuichiro Semba; Masatoshi Fujita; Yuko Sato; Hiroshi Kimura; Akihito Harada; Yasuyuki Ohkawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Histone H3.3 sub-variant H3mm7 is required for normal skeletal muscle regeneration.

Authors:  Akihito Harada; Kazumitsu Maehara; Yusuke Ono; Hiroyuki Taguchi; Kiyoshi Yoshioka; Yasuo Kitajima; Yan Xie; Yuko Sato; Takeshi Iwasaki; Jumpei Nogami; Seiji Okada; Tetsuro Komatsu; Yuichiro Semba; Tatsuya Takemoto; Hiroshi Kimura; Hitoshi Kurumizaka; Yasuyuki Ohkawa
Journal:  Nat Commun       Date:  2018-04-11       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.